Program Director: Andrew Farb, MD – U.S. Food and Drug Administration
Program Director: Aaron V. Kaplan, MD, FSCAI, FACC, FNAI – Dartmouth Health Geisel School of Medicine at Dartmouth
Program Director: Mitchell Krucoff, MD, FACC (he/him/his) – Duke University Medical Center/Duke Clinical Research Institute
Program Director: Changfu Wu, PhD – Food and Drug Administration
Program Director: Bram Zuckerman, MD – U.S. Food and Drug Administration
Moderator: Dorothy B. Abel, BSBME – NAMSA/Syntactx
Moderator: Andrew Farb, MD – U.S. Food and Drug Administration
Moderator: Aaron V. Kaplan, MD, FSCAI, FACC, FNAI – Dartmouth Health Geisel School of Medicine at Dartmouth
Speaker: Andrew Farb, MD – U.S. Food and Drug Administration
Speaker: Aaron V. Kaplan, MD, FSCAI, FACC, FNAI – Dartmouth Health Geisel School of Medicine at Dartmouth
Speaker: Katherine Kumar, PhD, RAC – 4C Medical Technologies, Inc.
Speaker: Charles A. Simonton, MD, FACC, FSCAI – Abiomed Inc
Speaker: Matthew G. Hillebrenner, MSE – U.S. Food and Drug Administration
Speaker: Steven Farmer, MD, PhD – CMS
Panel Moderator: Dorothy B. Abel, BSBME – NAMSA/Syntactx
Panel Moderator: Andrew Farb, MD – U.S. Food and Drug Administration
Panel Moderator: Aaron V. Kaplan, MD, FSCAI, FACC, FNAI – Dartmouth Health Geisel School of Medicine at Dartmouth
Panel Discussant: Todd J. Brinton, MD – Edwards Lifesciences
Panel Discussant: Keith D. Dawkins, MD, FACC, FSCAI, FRCP – Shockwave Medical Inc
Panel Discussant: Steven Farmer, MD, PhD – CMS
Panel Discussant: Matthew G. Hillebrenner, MSE – U.S. Food and Drug Administration
Panel Discussant: A Pieter Kappetein, MD, PhD (he/him/his) – Medtronic
Panel Discussant: Katherine Kumar, PhD, RAC – 4C Medical Technologies, Inc.
Panel Discussant: Semih Oktay, PhD – Cardiomed Device Consultants
Panel Discussant: Charles A. Simonton, MD, FACC, FSCAI – Abiomed Inc
Panel Discussant: Ron Waksman, MD, MSCAI – MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
Panel Discussant: Nick E. West, MA MD FRCP FESC FACC – Abbott Vascular
Panel Discussant: Changfu Wu, PhD – Food and Drug Administration
Speaker: William H. Maisel, MD, MPH (he/him/his) – U.S. Food and Drug Administration
Panel Discussant: William H. Maisel, MD, MPH (he/him/his) – U.S. Food and Drug Administration
Moderator: Mitchell Krucoff, MD, FACC (he/him/his) – Duke University Medical Center/Duke Clinical Research Institute
Moderator: Bram Zuckerman, MD – U.S. Food and Drug Administration
Speaker: Robert W. Yeh, MD, MSc – Beth Israel Deaconess Medical Center
Speaker: Ori Ben-Yehuda, MD (he/him/his) – University of California, San Diego
Speaker: Roseann M. White, MA – Edwards Lifesciences
Speaker: Rebecca Torguson, MPH – FDA
Panel Moderator: Mitchell Krucoff, MD, FACC (he/him/his) – Duke University Medical Center/Duke Clinical Research Institute
Panel Moderator: Bram Zuckerman, MD – U.S. Food and Drug Administration
Panel Discussant: Dominic Allocco, MD, MS – Boston Scientific
Panel Discussant: Ori Ben-Yehuda, MD (he/him/his) – University of California, San Diego
Panel Discussant: Keith D. Dawkins, MD, FACC, FSCAI, FRCP – Shockwave Medical Inc
Panel Discussant: Neal E. Fearnot, PhD – Cook Group Incorporated
Panel Discussant: Gerardine Finn, BS – Medtronic Inc.
Panel Discussant: Nicole Ibrahim, PhD – U.S. Food and Drug Administration
Panel Discussant: William H. Maisel, MD, MPH (he/him/his) – U.S. Food and Drug Administration
Panel Discussant: Misti Malone, PhD (she/her/hers) – FDA
Panel Discussant: Rebecca Torguson, MPH – FDA
Panel Discussant: Roseann M. White, MA – Edwards Lifesciences
Panel Discussant: Robert W. Yeh, MD, MSc – Beth Israel Deaconess Medical Center
Moderator: Jodi J. Akin, MS – Hawthorne Effect, Inc.
Moderator: Joaquin E. Cigarroa, MD – OHSU Knight Cardiovascular Institute
Moderator: Robert Kazmierski, PhD – FDA / CDRH
Speaker: Peter J. Fitzgerald, MD, PhD – Stanford University
Speaker: Kimberly Crowley, MS (she/her/hers) – FDA
Panel Moderator: Jodi J. Akin, MS – Hawthorne Effect, Inc.
Panel Moderator: Joaquin E. Cigarroa, MD – OHSU Knight Cardiovascular Institute
Panel Moderator: Robert Kazmierski, PhD – FDA / CDRH
Panel Moderator: Jessica Paulsen
Panel Discussant: Dominic Allocco, MD, MS – Boston Scientific
Panel Discussant: Kimberly Crowley, MS (she/her/hers) – FDA
Panel Discussant: Peter J. Fitzgerald, MD, PhD – Stanford University
Moderator: Donald E. Cutlip, MD, FACC (he/him/his) – Beth Israel Deaconess Medical Center
Moderator: P F Adrian Magee, MD – FDA
Speaker: Lydia Glaw, PhD – US FDA
Speaker: Hector M. Garcia-Garcia, MD, PhD – MedStar Washington Hospital Center
Panel Moderator: Donald E. Cutlip, MD, FACC (he/him/his) – Beth Israel Deaconess Medical Center
Panel Moderator: P F Adrian Magee, MD – FDA
Panel Discussant: Paula V. Caposino, PhD (she/her/hers) – FDA
Panel Discussant: Rafael Cavalcante, MD (he/him/his) – Boston Scientific
Panel Discussant: Hector M. Garcia-Garcia, MD, PhD – MedStar Washington Hospital Center
Panel Discussant: Lydia Glaw, PhD – US FDA
Panel Discussant: P F Adrian Magee, MD – FDA
Panel Discussant: Eugene P. McFadden, MD (he/him/his) – Cork University Hospital
Panel Discussant: Gregg W. Stone, MD, FACC, MSCAI – Mount Sinai
Panel Discussant: Jacqueline Wieneke, MD
Panel Moderator: Gregg W. Stone, MD, FACC, MSCAI – Mount Sinai
Panel Moderator: Ron Waksman, MD, MSCAI – MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
Panel Discussant: Aneesh Deoras
Panel Discussant: Andrew Farb, MD – U.S. Food and Drug Administration
Panel Discussant: Matthew G. Hillebrenner, MSE – U.S. Food and Drug Administration
Panel Discussant: Nicole Ibrahim, PhD – U.S. Food and Drug Administration
Panel Discussant: Rachel Neubrander, PhD – U.S. Food and Drug Administration
Panel Discussant: Brian Pullin, MS – FDA
Panel Discussant: Jaime Raben, PhD – FDA
Panel Discussant: Stuart F. Seides, MD, FSCAI – MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
Panel Discussant: Changfu Wu, PhD – Food and Drug Administration
Panel Discussant: Bram Zuckerman, MD – U.S. Food and Drug Administration